Tazomeline

Tazomeline
Clinical data
Other namesLY-287,041; LY-287041; LY287041; 3-Hexylthio-TZTP
ATC code
  • None
Identifiers
  • 5-[4-(hexylsulfanyl)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H23N3S2
Molar mass297.48 g·mol−1
3D model (JSmol)
  • n2snc(/C1=C/CCN(C)C1)c2SCCCCCC

Tazomeline (LY-287,041) is a drug which acts as a non-selective muscarinic acetylcholine receptor agonist. It was in clinical trials for the treatment of cognitive dysfunction such as that seen in Alzheimer's disease and schizophrenia, but development was apparently scrapped for unknown reasons. Another of the patented uses is for the treatment of "severe painful conditions".

See also